129 related articles for article (PubMed ID: 31142578)
1. Severe Acute Respiratory Failure in Healthy Adolescents Exposed to Trimethoprim-Sulfamethoxazole.
Miller JO; Taylor J; Goldman JL
Pediatrics; 2019 Jun; 143(6):. PubMed ID: 31142578
[TBL] [Abstract][Full Text] [Related]
2. Definition and Clinical Evaluation for Trimethoprim-Sulfamethoxazole Severe Acute Respiratory Failure.
Miller J; Khan H; Mino-Kenudson M; Taylor M; Shih A; Goldman J
Crit Care Med; 2023 Dec; 51(12):e264-e268. PubMed ID: 37449964
[TBL] [Abstract][Full Text] [Related]
3. Trimethoprim-sulfamethoxazole-induced hepatotoxicity in a pediatric patient.
Bell TL; Foster JN; Townsend ML
Pharmacotherapy; 2010 May; 30(5):539. PubMed ID: 20412003
[TBL] [Abstract][Full Text] [Related]
4. Interstitial lung disease during trimethoprim/sulfamethoxazole administration.
Yuzurio S; Horita N; Shiota Y; Kanehiro A; Tanimoto M
Acta Med Okayama; 2010 Jun; 64(3):181-7. PubMed ID: 20596129
[TBL] [Abstract][Full Text] [Related]
5. High daily doses of trimethoprim/sulfamethoxazole are an independent risk factor for adverse reactions in patients with pneumocystis pneumonia and AIDS.
Chang HM; Tsai HC; Lee SS; Kunin C; Lin PC; Wann SR; Chen YS
J Chin Med Assoc; 2016 Jun; 79(6):314-9. PubMed ID: 27025225
[TBL] [Abstract][Full Text] [Related]
6. Trimethoprim-Sulfamethoxazole-associated Fulminant Respiratory Failure in Children and Young Adults.
Miller JO; Shih AR; Mino-Kenudson M; Taylor MS; Goldman JL
Am J Respir Crit Care Med; 2021 Apr; 203(7):918-921. PubMed ID: 33513317
[No Abstract] [Full Text] [Related]
7. Renal Insufficiency in Concert with Renin-angiotensin-aldosterone Inhibition Is a Major Risk Factor for Hyperkalemia Associated with Low-dose Trimethoprim-sulfamethoxazole in Adults.
Higashioka K; Niiro H; Yoshida K; Oryoji K; Kamada K; Mizuki S; Yokota E
Intern Med; 2016; 55(5):467-71. PubMed ID: 26935365
[TBL] [Abstract][Full Text] [Related]
8. Severe ehrlichiosis in an adolescent taking trimethoprim-sulfamethoxazole.
Peters TR; Edwards KM; Standaert SM
Pediatr Infect Dis J; 2000 Feb; 19(2):170-2. PubMed ID: 10694012
[No Abstract] [Full Text] [Related]
9. Trimethoprim-sulfamethoxazole induced circulatory shock in a human immunodeficiency virus uninfected patient: a case report and review.
Liu P; Ranches GP; Gold JA
BMC Pharmacol Toxicol; 2018 Nov; 19(1):76. PubMed ID: 30458864
[TBL] [Abstract][Full Text] [Related]
10. Use of trimethoprim-sulfamethoxazole to prevent bacterial infections in children with acute lymphoblastic leukemia.
Goorin AM; Hershey BJ; Levin MJ; Siber GR; Gelber RD; Flynn K; Lew M; Beckett K; Blanding P; Sallan SE
Pediatr Infect Dis; 1985; 4(3):265-9. PubMed ID: 3889875
[TBL] [Abstract][Full Text] [Related]
11. The efficacy and safety of amoxicillin, trimethoprim-sulfamethoxazole, and spironolactone for treatment-resistant acne vulgaris.
Turowski CB; James WD
Adv Dermatol; 2007; 23():155-63. PubMed ID: 18159900
[TBL] [Abstract][Full Text] [Related]
12. Atypical Severe Shock-like Reactions in Adolescents After Trimethoprim-Sulfamethoxazole Therapy.
Rathe JA; Poole N; Melvin A
J Pediatric Infect Dis Soc; 2021 Apr; 10(3):382-385. PubMed ID: 32955095
[TBL] [Abstract][Full Text] [Related]
13. Incidence of Hyponatremia with High-Dose Trimethoprim-Sulfamethoxazole Exposure.
Tsapepas D; Chiles M; Babayev R; Rao MK; Jaitly M; Salerno D; Mohan S
Am J Med; 2016 Dec; 129(12):1322-1328. PubMed ID: 27542610
[TBL] [Abstract][Full Text] [Related]
14. Acute fibrinous organising pneumonia: a manifestation of trimethoprim-sulfamethoxazole pulmonary toxicity.
Jamous F; Ayaz SZ; Choate J
BMJ Case Rep; 2014 Oct; 2014():. PubMed ID: 25355746
[TBL] [Abstract][Full Text] [Related]
15. Trimethoprim-Sulfamethoxazole Associated Drug-Induced Liver Injury in Pediatrics: A Systematic Review.
Burgos RM; Reynolds KM; Williams J; Li W; Yan CH
Pediatr Infect Dis J; 2020 Sep; 39(9):824-829. PubMed ID: 32282528
[TBL] [Abstract][Full Text] [Related]
16. Treatment of brucellosis in a young child with trimethoprim/sulfamethoxazole anaphylaxis.
Teker D; Tanir G; Ozmen S; Teke TA; Keles S; Bostancı I
J Infect Public Health; 2014; 7(6):553-6. PubMed ID: 25182510
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of upfront graded administration of trimethoprim-sulfamethoxazole in systemic lupus erythematosus: A retrospective cohort study.
Suyama Y; Okada M; Rokutanda R; Min C; Sassé B; Kobayashi D; Takahashi O; Deshpande GA; Matsui K; Kawaguchi Y; Kishimoto M
Mod Rheumatol; 2016 Jul; 26(4):557-61. PubMed ID: 26587755
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness and safety of lower dose sulfamethoxazole/trimethoprim therapy for Pneumocystis jirovecii pneumonia in patients with systemic rheumatic diseases: A retrospective multicenter study.
Ohmura SI; Naniwa T; Tamechika SY; Miyamoto T; Shichi D; Kazawa N; Iwagaitsu S; Maeda S; Wada JI; Niimi A
J Infect Chemother; 2019 Apr; 25(4):253-261. PubMed ID: 30642768
[TBL] [Abstract][Full Text] [Related]
19. A comparison of adverse drug reactions between high- and standard-dose trimethoprim-sulfamethoxazole in the ambulatory setting.
Nguyen AT; Gentry CA; Furrh RZ
Curr Drug Saf; 2013 Apr; 8(2):114-9. PubMed ID: 23713542
[TBL] [Abstract][Full Text] [Related]
20. The use of trimethoprim and sulfamethoxazole (TMP-SMX) in dermatology.
Michałek K; Lechowicz M; Pastuszczak M; Wojas-Pelc A
Folia Med Cracov; 2015; 55(1):35-41. PubMed ID: 26774630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
